{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:49:09Z","timestamp":1792882149396,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jsat.2019.08.009","type":"journal-article","created":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T11:45:09Z","timestamp":1565955909000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder"],"prefix":"10.1016","volume":"107","author":[{"given":"Elise E.","family":"DeVito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Babuscio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charla","family":"Nich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Sofuoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jsat.2019.08.009_bb0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00002512-200926030-00004","article-title":"Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: Post hoc analysis of a randomized, double-blind, placebo-controlled trial","volume":"26","author":"Aronson","year":"2009","journal-title":"Drugs & Aging"},{"key":"10.1016\/j.jsat.2019.08.009_bb0010","doi-asserted-by":"crossref","first-page":"e713","DOI":"10.1038\/tp.2015.209","article-title":"Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers","volume":"6","author":"Ashare","year":"2016","journal-title":"Translational Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2019.08.009_bb0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/appi.ajp.2007.07050724","article-title":"Galantamine for the treatment of cognitive impairments in people with schizophrenia","volume":"165","author":"Buchanan","year":"2008","journal-title":"The American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.jsat.2019.08.009_bb0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/ajad.12904","article-title":"Double-blind placebo-controlled trial of galantamine for methadone-maintained individuals with cocaine use disorder: Secondary analysis of effects on illicit opioid use","volume":"28","author":"Carroll","year":"2019","journal-title":"The American Journal on Addictions"},{"issue":"1","key":"10.1016\/j.jsat.2019.08.009_bb0025","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11669","article-title":"Galantamine and computerized cognitive behavioral therapy for cocaine dependence: A randomized clinical trial","volume":"79","author":"Carroll","year":"2018","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2019.08.009_bb0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drugalcdep.2017.10.022","article-title":"Drug Stroop: Mechanisms of response to computerized cognitive behavioral therapy for cocaine dependence in a randomized clinical trial","volume":"183","author":"DeVito","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.jsat.2019.08.009_bb0035","doi-asserted-by":"crossref","first-page":"614","DOI":"10.5414\/CPP44614","article-title":"Galantamine reduces smoking in alcohol-dependent patients: A randomized, placebo controlled trial","volume":"44","author":"Diehl","year":"2006","journal-title":"International Journal of Clinical Pharmacology & Therapeutics"},{"issue":"3\u20134","key":"10.1016\/j.jsat.2019.08.009_bb0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0306-4603(78)90024-2","article-title":"Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment","volume":"3","author":"Fagerstrom","year":"1978","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2019.08.009_bb0045","series-title":"Structured clinical interview for DSM-IV Axis I disorders patient edition","author":"First","year":"1996"},{"issue":"4","key":"10.1016\/j.jsat.2019.08.009_bb0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.phrs.2003.11.017","article-title":"Cholinesterase inhibitors: New roles and therapeutic alternatives","volume":"50","author":"Giacobini","year":"2004","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.jsat.2019.08.009_bb0055","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bbr.2016.06.022","article-title":"A threshold model for opposing actions of acetylcholine on reward behavior: Molecular mechanisms and implications for treatment of substance abuse disorders","volume":"312","author":"Grasing","year":"2016","journal-title":"Behavioural Brain Research"},{"issue":"1","key":"10.1016\/j.jsat.2019.08.009_bb0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/FBP.0b013e3283428cd8","article-title":"Reversible and persistent decreases in cocaine self-administration after cholinesterase inhibition: Different effects of donepezil and rivastigmine","volume":"22","author":"Grasing","year":"2011","journal-title":"Behavioural Pharmacology"},{"issue":"10","key":"10.1016\/j.jsat.2019.08.009_bb0065","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1073\/pnas.0631749100","article-title":"Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine","volume":"100","author":"Hikida","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.jsat.2019.08.009_bb0070","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.coph.2007.10.014","article-title":"Accumbens dopamine-acetylcholine balance in approach and avoidance","volume":"7","author":"Hoebel","year":"2007","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.jsat.2019.08.009_bb0075","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.drugalcdep.2017.08.031","article-title":"Trends and correlates of cocaine use and cocaine use disorder in the United States from 2011 to 2015","volume":"180","author":"John","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2019.08.009_bb0080","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0306-4603(98)00011-2","article-title":"Reliability and validity of the cocaine selective severity assessment","volume":"23","author":"Kampman","year":"1998","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2019.08.009_bb0085","first-page":"343","article-title":"SAFTEE: A technique for the systematic assessment of side effects in clinical trials","author":"Levine","year":"1986","journal-title":"Psychopharmacology Bulletin"},{"issue":"8","key":"10.1016\/j.jsat.2019.08.009_bb0090","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.neuropharm.2012.01.031","article-title":"Galantamine attenuates the heroin seeking behaviors induced by cues after prolonged withdrawal in rats","volume":"62","author":"Liu","year":"2012","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.jsat.2019.08.009_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2665","article-title":"Effects of galantamine on smoking behavior and cognitive performance in treatment-seeking smokers prior to a quit attempt","volume":"33","author":"MacLean","year":"2018","journal-title":"Human Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jsat.2019.08.009_bb0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archpsyc.63.2.201","article-title":"Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A National Drug Abuse Treatment Clinical Trials Network study","volume":"63","author":"Peirce","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"10","key":"10.1016\/j.jsat.2019.08.009_bb0105","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/archpsyc.62.10.1148","article-title":"Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A national drug abuse treatment clinical trials network study","volume":"62","author":"Petry","year":"2005","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1016\/j.jsat.2019.08.009_bb0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/00952990701199416","article-title":"Treatment outcome predictors for cocaine dependence","volume":"33","author":"Poling","year":"2007","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2019.08.009_bb0115","series-title":"Medical Defense Biosciences Review","article-title":"The UTCPAB and the NATO AGARD STRES battery: Results from standardization studies","author":"Reeves","year":"1991"},{"key":"10.1016\/j.jsat.2019.08.009_bb0120","series-title":"ANAM 2001's User's manual","author":"Reeves","year":"2002"},{"issue":"8","key":"10.1016\/j.jsat.2019.08.009_bb0125","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2165\/00023210-200620080-00006","article-title":"Galantamine extended release","volume":"20","author":"Robinson","year":"2006","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.jsat.2019.08.009_bb0130","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1111\/ejn.12515","article-title":"Deterministic functions of cortical acetylcholine","volume":"39","author":"Sarter","year":"2014","journal-title":"European Journal of Neuroscience"},{"issue":"1","key":"10.1016\/j.jsat.2019.08.009_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.npp.1301087","article-title":"Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors","volume":"32","author":"Schilstrom","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jsat.2019.08.009_bb0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addbeh.2017.11.044","article-title":"The effect of N-acetylcysteine and working memory training on cocaine use, craving and inhibition in regular cocaine users: Correspondence of lab assessments and ecological momentary assessment","volume":"79","author":"Schulte","year":"2018","journal-title":"Addictive Behaviors"},{"issue":"1","key":"10.1016\/j.jsat.2019.08.009_bb0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1360-0443.2009.02791.x","article-title":"Cognitive enhancement as a pharmacotherapy target for stimulant addiction","volume":"105","author":"Sofuoglu","year":"2010","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.jsat.2019.08.009_bb0150","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1521-0391.2011.00130.x","article-title":"Effects of galantamine on cocaine use in chronic cocaine users","volume":"20","author":"Sofuoglu","year":"2011","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2019.08.009_bb0155","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neuropharm.2012.06.021","article-title":"Cognitive enhancement as a treatment for drug addictions","volume":"64","author":"Sofuoglu","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.jsat.2019.08.009_bb0160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/15504263.2016.1146383","article-title":"Cognitive function as a Transdiagnostic treatment target in stimulant use disorders","volume":"12","author":"Sofuoglu","year":"2016","journal-title":"Journal of Dual Diagnosis"},{"issue":"11","key":"10.1016\/j.jsat.2019.08.009_bb0165","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2165\/11310920-000000000-00000","article-title":"Cholinergic functioning in stimulant addiction","volume":"23","author":"Sofuoglu","year":"2009","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.jsat.2019.08.009_bb0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1037\/a0022213","article-title":"Galantamine improves sustained attention in chronic cocaine users","volume":"19","author":"Sofuoglu","year":"2011","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2019.08.009_bb3005","series-title":"Wechsler Adult Intelligence Scale-Fourth Edition: Administration and scoring manual","author":"Wechsler","year":"2008"},{"issue":"6","key":"10.1016\/j.jsat.2019.08.009_bb0175","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0091-3057(73)90027-0","article-title":"Cholinergic influence on intravenous cocaine self-administration by rhesus monkeys","volume":"1","author":"Wilson","year":"1973","journal-title":"Pharmacology Biochemistry and Behavior"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219303009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219303009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:50:12Z","timestamp":1760039412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547219303009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":36,"alternative-id":["S0740547219303009"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2019.08.009","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2019.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}